Assay validation

• Acknowledgements: Denis Guedin (HMR, Romainville), Weimin Tang (HMR, Bridgewater)

• Data from optimized SPA assay with inactive compounds spiked with known inhibitor

Inactive compounds

Low controls

Spiked actives

Previous slide

Next slide

Back to first slide

View graphic version